Letter regarding Article, "Clinical outcomes and sustainability of using CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention"

by Aw JWX, Tan DSY, Goh LL
Published 2020

Switching of P2Y12 Inhibitors in Acute Coronary Syndromes

by Leong WQ, Kim JH, Aw JWX, Tan DSY
Published 2020

Comparison of rivaroxaban concentrations between Asians and Caucasians and their correlation with PT/INR

by Ng HOT, Goh JJN, Aw JWX, Lin YY, Fong AYY, Tiong LL, Tan D
Published 2020

CYP2C19 phenotype in South?East Asian Acute Coronary Syndrome patients and impact on major adverse cardiovascular events

by Tan DS, Aw JWX, Winther M, Goh LL, Ong HY, Wee E, Liu J, Ho HK, J Clin Pharm Ther
Published 2020